TFS HealthScience establishes operation in Australia expanding its CRO capabilities to APAC

TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), has expanded into the Asia Pacific&...

March 12, 2024 | Tuesday | News
Researchers in Australia develop blood-based marker to identify sleep deprivation

A blood test that can accurately detect when someone has not slept for 24 hours has been developed by a Monash Universit...

March 12, 2024 | Tuesday | News
Australia drives MRFF’s Genomics Health Futures Mission under $500 M initiative

The Australian Government has appointed health system and genomic experts to guide investments under the MRFF’s "G...

March 11, 2024 | Monday | News
Australia commits $3 M to assist in elimination of dengue fever in Laos

Monash University’s World Mosquito Programme (WMP) has received significant funding from the Australian Department...

March 8, 2024 | Friday | News
Australia's Telix Pharma buys radioisotope production technology firm ARTMS for $42.5 M

Australia-based Telix Pharmaceuticals has entered into an agreement to acquire radioisotope production technology firm A...

March 6, 2024 | Wednesday | News
Queensland's Southern RNA joins forces with DKSH to advance biotech collaborations with India

Queensland-based Southern RNA, a leading Contract Development and Manufacturing Organisation (CDMO) specialising in...

March 5, 2024 | Tuesday | News
Australia to propel projects minimising antimicrobial resistance

Australia’s leading national biotech incubator, CUREator by Brandon BioCatalyst, has announced the allocation of $...

March 4, 2024 | Monday | News
Engineers in Australia design 5-minute full body MRI scanner using AI

In a study published in Computers in Biology and Medicine, researchers at Monash University in Australia have shown how ...

March 1, 2024 | Friday | News
Synthetic biology advances to generate $30 B opportunity for Australia

Synthetic biology could underpin an industry worth up to $30 billion per year and create over 50,000 new jobs by 2040, a...

February 29, 2024 | Thursday | News
BioCina and NovaCina partners to accelerate global end-to-end biopharmaceutical manufacturing solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina...

February 28, 2024 | Wednesday | News
Australian firm Telix Pharma expands US infrastructure with acquisition of IsoTherapeutics

Australia-based Telix Pharmaceuticals has entered into an agreement to acquire IsoTherapeutics Group, LLC, a specialty r...

February 27, 2024 | Tuesday | News
Experts map and describe health research digital ecosystem in Queensland

Health Translation Queensland (HTQ) has launched a snapshot of Queensland’s health research digital ecosystem whic...

February 26, 2024 | Monday | News
Australian govt injects $50 M to construct world-leading artificial heart

The Australian government is providing $50 million to develop and commercialise the world’s most advanced artifici...

February 20, 2024 | Tuesday | News
Korean startup AIRS Medical takes AI-powered MRI solutions to Australia & New Zealand

South Korea-based startup AIRS Medical Inc., a leading provider of artificial intelligence (AI)-powered healthcare solut...

February 19, 2024 | Monday | News
Australia establishes new task force to guide use of AI in public health system

New South Wales (NSW) Health in Australia has established a new taskforce to inform and guide the use of artificia...

February 15, 2024 | Thursday | News
University of Sydney signs precision-medicine research partnership with Bruker

Researchers at the University of Sydney, Australia have taken a significant stride forward in precision medicine, with t...

February 13, 2024 | Tuesday | News
Biocon Biologics partners with Sandoz Australia for cancer biosimilars

Indian firm Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon, has announ...

February 9, 2024 | Friday | News
Australia's Recce partners Indonesia's Etana Biotech to advance anti-infective R&D, manufacturing 

Recce Pharmaceuticals Limited, the Company developing a New Class of Synthetic Anti-Infectives, has signed Memorand...

February 8, 2024 | Thursday | News